Cell Viability Assays Market Accretes A Phenomenal Growth By 2023 With A Striking ~ 9.2 % CAGR| Top Key Players Analysis Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton Dickinson & Company, Promega Co

Market Scenario:

Global cell Viability Assays market is expected to grow significantly over the forecast period. It is estimated that the global cell Viability Assays market is expected to register a CAGR ~ 9.2% during the forecast period of 2018–2023.

Cell-based assays are techniques used for the screening collections of compounds to find out if the test molecules have any effect on cell proliferation or show direct cytotoxic effects that eventually lead to cell death. The measurement of cell viability plays a significant role in all forms of cell culture. The main application of cell viability is to determine whether the cells are alive. For instance, in cancer research, cell viability assays are used to confirm the killing of tumor cells and to verify the survival of normal cells.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6391

Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market. For instance, in 2015, the National Institutes of Health invested around 1,429 million USD for stem cells research. Moreover, increasing focus on developing cell-based therapeutics boosts the growth of the market. However, the rising cost of the instruments may hamper the market growth during the assessment period.

Key Players

Thermo Fisher Scientific
Merck KGaA
Bio-Rad Laboratories
G E Healthcare
Danaher Corporation
Becton, Dickinson and Company
Promega Corporation
Biotium
Abcam plc
Creative Bioarray
Biotek Instruments
PerkinElmer
Segmentation

The market has been segmented into products, cell type, applications, and end-user.

The market, on the basis of products, has been segmented into consumables and instruments.

The consumables segment has been further divided into reagents, assay kits, and microplates. The Assay kits segment has been further segmented into tetrazolium reduction assay kits, resazurin cell Viability Assays kits, calcein-Am cell Viability Assays kits and other assay kits. Furthermore, tetrazolium assay kits have been classified into MIT assay kits and other tetrazolium assay kits.

The instruments have been segmented into automated cell counters, flow cytometers, spectrophotometers, and cell imaging & analysis systems.

The market, by cell type, has been segmented into human cells, microbial cells, and animal cells.

The market, by applications, has been segmented into stem cell research, clinical & diagnostic applications, drug discovery & development, and others.

The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospital & diagnostic laboratories and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The cell Viability Assays market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European cell Viability Assays market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The cell Viability Assays market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cell Viability Assays market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global cell Viability Assays market owing to a well-developed healthcare sector, rising prevalence of infectious and chronic diseases and growing healthcare expenditure. According to an article published by the Centers for Medicare and Medicaid Services in August 2018, the US healthcare spending had reached USD 3.3 trillion in 2016. Europe is expected to hold the second largest position in the global cell Viability Assays market. The market growth in this region is attributed to the growing prevalence of chronic diseases and increasing healthcare expenditure. According to a report published by EU observer in September 2014, more than the one-third population of Europe above the age of 15 years in suffering from a chronic disease and 2 in every 3 people reaching the age of retirement have at least 2 chronic diseases.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising number of stem cell, proteomics, and genomics research activities. Also, increased expenditure in the healthcare sector is expected to boost the growth in this market.

On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/6391

Detailed Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/6391

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.